Janssen CarePath Patient Resource
Janssen CarePath provides information about access and affordability support for patients who have been prescribed Janssen medicines. Similar information is available through Actelion Pathways® for patients prescribed Actelion medicines.
- Cost support for commercially eligible patients starting or continuing on certain Janssen or Actelion medicines
- Free trial products for new patients starting on most medicines
- Referral to independent foundations that offer free medicines for patients who have lost their jobs and insurance coverage
About Janssen CarePath
Janssen CarePath provides access, affordability, and treatment support resources to help patients get started on, and stay on, the Janssen medications their healthcare providers prescribe.
For commercially insured patients who meet the program requirements, we offer the Janssen CarePath Savings Program to help reduce patient out-of-pocket medication costs for prescribed Janssen medications. Additionally, Janssen CarePath helps healthcare providers find access solutions for their patients by verifying patients’ health insurance benefits to make sure providers are familiar with their patients’ coverage for Janssen medicines and any requisite prior authorization, step therapy, or other payer policies.
In 2019, the Janssen Pharmaceutical Companies of Johnson & Johnson helped approximately 1.3 million patients through the Janssen CarePath program. This includes approximately 540,000 commercially insured patients who reduced their out-of-pocket expenditures through the Janssen CarePath Savings Program.
About Actelion Pathways®
Actelion Pathways® is a resource to support patients who have been prescribed an Actelion therapy.